• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits

    11/20/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email

    A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.

    Nearly 6,000 beneficiaries receiving care under Humana Medicare Advantage health plans with supplemental benefits participated in the survey, representing a robust sample for this patient-centered research.

    The results highlighted four principal insights into the use and value of supplemental benefits:

    • More than 90 percent of participants agreed or strongly agreed that these benefits can improve health and save individuals money;
    • Beneficiaries who reported using their supplemental benefits reported finding them highly valuable;
    • Among those who did not use a supplemental benefit, the most common reason cited for not using it was not needing it during the plan year, indicating that non-use was primarily driven by lack of need rather than barriers or lack of awareness; and
    • There are opportunities for health plans to improve the user experience by addressing limitations in how benefits are communicated and offered.

    "We were struck by how deeply Medicare Advantage beneficiaries value their supplemental benefits, which underscores their importance to the health and well-being of our members," said Missy Caple, Vice President of Medicare Product Development at Humana. "These survey results also bring attention to the evolving priorities within the Medicare population and the importance of providing clear communication throughout the beneficiary experience."

    "Given the rapid growth of Medicare Advantage supplemental benefits in recent years, policymakers need better insight into how MA members use and value them," said Eric Roberts, Associate Professor at Perelman School of Medicine at the University of Pennsylvania. "Surveys like this are a key step toward that understanding and lay the groundwork for future studies evaluating their impact on member outcomes."

    In 2025, 54% of eligible Medicare beneficiaries, approximately 34.1 million people, were enrolled in a Medicare Advantage plan including supplemental benefits. Supplemental benefits offered through Medicare Advantage plans have long included a variety of options, such as dental, vision, and hearing benefits, in addition to services like non-emergency transportation, wellness programs, over-the-counter medications, and grocery financial assistance.

    The survey offered insights into the most and least frequently utilized supplemental benefits, dove into which benefits were highly valued when used, and studied why certain benefits were used less often. Findings suggest that while not all beneficiaries use every benefit, they are highly valued and needed by those who use them.

    Access the full survey white paper here to learn more about the survey methodology, beneficiary responses, and opportunities for Medicare Advantage plans to enhance beneficiary awareness, usability, and coverage of benefit offerings.

    About Humana

    Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251120160089/en/

    Media Contact

    Lisa Dimond

    Humana Corporate Communications

    [email protected]

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Humana Inc.

    DEFA14A - HUMANA INC (0000049071) (Filer)

    3/6/26 7:32:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Humana Inc.

    DEF 14A - HUMANA INC (0000049071) (Filer)

    3/6/26 7:30:53 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form FWP filed by Humana Inc.

    FWP - HUMANA INC (0000049071) (Subject)

    3/5/26 5:22:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Assigns Issue Credit Rating to Humana Inc.'s New Junior Subordinated Notes

    AM Best has assigned a Long-Term Issue Credit Rating of "bbb-" (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged. Humana expects to use the proceeds from the junior subordinated notes issuance for general corporate purposes, which may include repayment of existing indebtedness, including borrowings under its commercial paper program. AM Best expects the issuance to increase financial leverage slightly in the intermediate term. The company's financial leverage, as

    3/6/26 11:04:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

    Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the "Junior Subordinated Notes Offering"). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering f

    3/5/26 7:08:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana partners with Disabled American Veterans for the sixth year

    ERLANGER, Ky., March 04, 2026 (GLOBE NEWSWIRE) -- DAV (Disabled American Veterans) has announced its continued partnership with Humana, one of the nation's leading health and well-being companies. The relationship builds on Humana's long-standing commitment to supporting veterans and expands its investment in organizations that provide critical programs and services for veterans and their families. Humana works to help people achieve their best health by partnering with communities, veterans service organizations, providers and clinicians to address challenges such as hunger, homelessness, financial strain, transportation barriers and loneliness—all factors that can impact veteran wel

    3/4/26 12:55:41 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Ventura Joseph C converted options into 1,035 units of Humana Common and covered exercise/tax liability with 478 units of Humana Common, increasing direct ownership by 3% to 17,087 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/26/26 5:09:07 PM ET
    $HUM
    Medical Specialities
    Health Care

    President, Insurance Renaudin George Ii covered exercise/tax liability with 419 units of Humana Common and converted options into 1,035 units of Humana Common, increasing direct ownership by 4% to 16,075 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/26/26 3:43:58 PM ET
    $HUM
    Medical Specialities
    Health Care

    SVP, Chief Accting Off & Cont. Felter John-Paul W. was granted 5,669 units of Humana Common, converted options into 165 units of Humana Common and covered exercise/tax liability with 84 units of Humana Common, increasing direct ownership by 332% to 7,484 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 4:04:34 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large.

    2/19/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care